Navigation Links
Accuray Launches New Organization for CyberKnife® and TomoTherapy® System Users
Date:8/31/2011

se visit us at ASTRO and online at: www.accurayexchange.com.  

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. Accuray's innovative technologies – the CyberKnife System and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company's technologies and more than 550 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to standards of patient care and safety and user base are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: personalized patient care, safety & efficacy, range of treatment options, clinical applications, a
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
2. Accuray Incorporated to Host Investor Meeting at ASTRO 2011
3. Accuray Symposium Puts Spotlight on Quality Assurance in Radiation Oncology at Joint AAPM/COMP Meeting
4. Accuray Announces Proposed Offering of $75 Million Convertible Senior Notes
5. Accuray Hosts Symposium on Quality Assurance in Radiation Oncology at Joint AAPM/COMP Meeting
6. Accurays CyberKnife and TomoTherapy Systems Highlighted at World Conference on Lung Cancer
7. Accuray Hosts Korean Embassys Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement
8. Accuray Successfully Completes Acquisition of TomoTherapy
9. TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy
10. Accuray Incorporateds CEO to Speak at Jefferies 2011 Global Healthcare Conference
11. Accuray Showcases CyberKnife Robotic Radiosurgery System at American Urological Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... LONDON , July 23, 2014  Lightlake ... developing addiction treatments based on its expertise in ... an investigational new drug application ("IND") with respect ... Lightlake also announced today that it has received ... Drug Abuse ("NIDA"), part of the National Institutes ...
(Date:7/23/2014)... , July 23, 2014  Silk Road ... the transcarotid treatment of intra- and extra-cranial cerebrovascular ... P. Wallace to the position of Chief ... lead the company,s Research and Development efforts across ... Prior to joining Silk Road ...
(Date:7/23/2014)... , July 23, 2014  ACON Equity Partners III, ... Investments, L.L.C. ("ACON") announced it has completed the purchase ... from Audax Group and Parthenon Capital Partners. IWP is ... billion Workers, Compensation, Automobile Personal Injury Protection and Personal ... . As part of this ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3ACON Investments Acquires Injured Workers Pharmacy 2ACON Investments Acquires Injured Workers Pharmacy 3
... Therapeutics, Inc. (Nasdaq: ECTE ), a company ... wireless, transdermal continuous glucose monitoring system and its Prelude® ... results for the year ended December 31, 2011.  Echo,s ... website at www.echotx.com . 2011 ...
...   Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) ... of senior vice president and chief commercial officer. Mr. Palekar ... activities. "Rohan has an outstanding track record of ... president and CEO of Avanir. "I am delighted that we ...
Cached Medicine Technology:Echo Therapeutics, Inc. Announces 2011 Financial Results 2Echo Therapeutics, Inc. Announces 2011 Financial Results 3Echo Therapeutics, Inc. Announces 2011 Financial Results 4Echo Therapeutics, Inc. Announces 2011 Financial Results 5Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer 2Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer 3
(Date:7/23/2014)... the secrets to better treating the pernicious disorders of ... a paper from American University,s Center for Behavioral Neuroscience. ... obesity with therapies aimed at areas of the brain ... on the hippocampus could play a role in reducing ... therapies and preventive measures often fall short. This is ...
(Date:7/23/2014)... 23, 2014 (HealthDay News) --,Jealousy may not be the ... can get downright possessive when it comes to the ... affection toward what was actually a stuffed dog, the ... pushing the stuffed dog aside, report researchers from the ... streak only surfaced when owners were attending to the ...
(Date:7/23/2014)... research on human cancer genes have been focused on ... to be translated in the form of amino acids ... a regulatory region or activator which controls the expression ... little was known of the role exerted such DNA ... today in Nature in collaboration with the ...
(Date:7/23/2014)... County, NJ (PRWEB) July 23, 2014 ... is the first hospital in New Jersey to receive ... most advanced robotics platform in the da Vinci series. ... and a profound step forward in innovation. The intuitive ... used across a wide spectrum of minimally invasive and ...
(Date:7/23/2014)... Vancouver, BC (PRWEB) July 23, 2014 ... has recently announced the launch of its custom orthotics ... correcting and eliminating foot abnormalities in order to restore ... the joints and cause less fatigue and pain. In ... and reduced pressure in the foot, resulting in relief ...
Breaking Medicine News(10 mins):Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:Dogs Can Get Jealous, Too 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:Custom Orthotics at Burnaby PhysioCare Now Correct Foot Abnormalities 2
... risk of obesity later in life, research suggests , ... during pregnancy reduces an infant,s birth weight, which may ... researchers say. , In a new study, 84 first-time ... groups, with those in the exercise group participating in ...
... ... Laboratory Notebook) to be fully supported on the revolutionary Apple iPad. , ... (PRWEB) April 5, 2010 -- Amphora Research ... supported on the revolutionary Apple iPad., , ,"Science often happens in places where using a ...
... ... today. This newly launched initiative from MedPage Today, the online daily breaking medical news ... and critical thinkers while preserving their editorial independence. , ... Little Falls, New Jersey (PRWEB) April 5, 2010 ...
... finds relationships often founder after failed pregnancy, , MONDAY, April ... when she miscarried at 14 weeks. That she was already ... understand was that having my other children and realizing how ... who lives in Highland Ranch, Colo. , At first, her ...
... ... Day on April 7th, Swanson Health Products will donate five percent of the day,s sales ... ... Health Products plans to donate five percent of sales from Wednesday, April 7th, to Vitamin ...
... ... Expanded Its Free Webinars to Cover New Obama Health Reform ... Insurance Reimbursement Checks Directly with Valid Assignment and Nondiscrimination Protections ... and Individual Health Plan to Accept Patient Assignment to Send ...
Cached Medicine News:Health News:Expectant Mom's Exercise Keeps Newborn's Birth Weight Down 2Health News:Amphora's PatentSafe Electronic Laboratory Notebook Fully Supported on the Apple iPad 2Health News:MedPage Today Launches New Related SitesTM Initiative with KevinMD.com as First Collaborator 2Health News:MedPage Today Launches New Related SitesTM Initiative with KevinMD.com as First Collaborator 3Health News:For Many Couples, Toll of Miscarriage Lingers 2Health News:For Many Couples, Toll of Miscarriage Lingers 3Health News:For Many Couples, Toll of Miscarriage Lingers 4Health News:Swanson Health Products to Make Donation for Haiti Relief Efforts 2Health News:Health Reform for Out-Of-Network Providers: Receiving Insurance Checks Directly? - Free Webinars on Why and How 2Health News:Health Reform for Out-Of-Network Providers: Receiving Insurance Checks Directly? - Free Webinars on Why and How 3Health News:Health Reform for Out-Of-Network Providers: Receiving Insurance Checks Directly? - Free Webinars on Why and How 4Health News:Health Reform for Out-Of-Network Providers: Receiving Insurance Checks Directly? - Free Webinars on Why and How 5
VascoScrew is a unipolar permanent pacing lead with a fixed screw a double flanch for permanent pacing. Due to latest technologies, VascoScrew D10/60 M is compatible to all pacemaker-cavities with th...
VascoScrew is a unipolar permanent pacing lead with a fixed screw a double flanch for permanent pacing. Due to latest technologies, VascoScrew D10/60 M is compatible to all pacemaker-cavities with th...
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products: